Ticket pricing in Indian cinema usually follows a fairly predictable logic. A franchise builds goodwill over its initial installments, and by the time the sequel arrives, exhibitors respond to the built-in demand by pushing premium formats and peak show pricing higher. They do this because the audience is already proven. What makes the current momentum around Toxic so fascinating is that it appears to be following this exact pricing pattern, despite being a standalone film with no prior installment to lean on. It is a rare trend in the trade, and the numbers reveal just how aggressive this strategy is.
To understand why this is unusual, we have to look at the benchmark set by recent major tentpoles. When the original Dhurandhar released in 2025, it established its base as a fresh IP with a Hindi 2D average ticket price (ATP) of 261 rupees, selling over 2.62 lakh tickets for a 9.23 crore advance opening. When the sequel, Dhurandhar 2: The Revenge, arrived, exhibitors leveraged that massive established success. The data showed a clear jump in confidence, with the Hindi 2D ATP rising to 322 rupees, while premium formats like Dolby Cinema averaged 664 rupees and IMAX 2D touched 770 rupees. This is the classic sequel trajectory: a significant price hike because the brand is already a household name.
Toxic, on the other hand, does not have the luxury of a Part 1 to fall back on. Yash has not had a theatrical release since 2022, and this film is not continuing an established story. Yet, the pricing decisions for Toxic mirror exactly what you would expect from a massive franchise sequel. The Hindi 2D average ticket price for the film has settled at 310 rupees. This means Toxic is walking into theaters with a pricing power that is almost identical to the 322 rupee benchmark of a major sequel like Dhurandhar 2, and significantly higher than the 261 rupee start of the original Dhurandhar.
While this strategy is rare for a standalone film, Toxic is joining an elite club of Event Cinema that has successfully bypassed the sequel requirement. We saw this blueprint first with RRR in 2022. Despite being a fresh IP, it secured government-sanctioned price hikes of ₹75 to ₹100 across Telugu states, while metro ticket rates in national chains reached as high as ₹2,100—matching the benchmarks of massive global franchises like Avengers: Endgame. It proved that a director's brand alone could command top-tier rates without a prior installment.
The trend was further solidified by Pathaan, which leveraged pure superstar pull to push the envelope. In Mumbai, single screens tripled their usual rates from ₹150 to ₹500, while the opening weekend average ticket price (ATP) in Delhi hit ₹360—nearly 40% higher than the average for standalone Hindi releases. Similarly, Animal maintained a massive ATP of ₹250+ across its first weekend, with premium IMAX tickets priced between ₹1,000 and ₹1,200, matching major sequels released in the same window. Toxic is now the latest entrant in this trend, proving that when the star power and hype are high enough, the Part 2 tag becomes optional.
The premium format numbers for Toxic further highlight this confidence. According to the Day 1 advance booking breakdown, the Kannada IMAX 2D format is carrying a staggering average ticket price of 1,474 rupees, while Kannada 4DX shows are averaging 1,182 rupees. On the Hindi side, while the 2D shows sit at 310 rupees, the 4DX format is commanding 761 rupees and IMAX shows are at 713 rupees. These aren't just standard rates; they are deliberate, top-tier premiums that suggest the industry is treating Yash’s presence as a self-contained cinematic universe.
The scale of engagement matches this high-value strategy. Toxic has already locked in an all-India advance gross of 32.64 crore, which jumps to 41.75 crore once blocked seats are included. With over 920,706 tickets sold across 18,969 shows, the film is maintaining a very competitive revenue-per-show ratio. In mass markets like Andhra Pradesh and Telangana, reports indicate that special early morning shows were priced between 500 and 600 rupees, cementing the idea that the film is being positioned as a premium event rather than just a regular Friday release.
So, what explains a standalone film getting sequel-level pricing? The answer lies in the evolution of stardom. Exhibitors are essentially pricing Yash's individual brand the way they would normally price franchise continuity. In the eyes of the trade, the star has become the IP. While a sequel that overprices itself has the safety net of an established fan base, a standalone film like Toxic is making a bold bet that the audience's willingness to pay is tied directly to the lead actor's screen presence. As the first shows begin, the actual walk-in numbers will be the final test of whether this star-as-a-franchise pricing model becomes the new industry standard.
Bollywood
